Related Experiment Video
Updated: Oct 9, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Chronic Methyl tert-butyl ether exposure disrupts neurodevelopment and selectively impairs dopaminergic neurons
Yun Hee So1, Dong Hun Lee1, Hyun Seung Shin1
1Laboratory of Molecular Neurobiology, Department of Molecular Biology, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea; Institute for Future Earth, Pusan National University, Busan 46241, Republic of Korea.
Abstract:
Methyl tert-butyl ether (MTBE) is a widely detected environmental contaminant, especially in the water; however, its impact on brain development remains poorly defined. Here, we show that chronic exposure to MTBE (15mg/mL in drinking water) beginning during embryonic development (E9.5) and continuing post-weaning for 18 weeks disrupts neuronal homeostasis and induces long-lasting alterations in dopaminergic neurons and behavior in C57BL/6J mice. In primary neuronal cultures, MTBE suppresses neuronal proliferation, increases apoptotic cell death, and impairs neurite outgrowth, indicating direct neurodevelopmental toxicity. In vivo, MTBE exposure resulted in a reduction of tyrosine hydroxylase-positive dopaminergic neurons, with preferential vulnerability in the ventral tegmental area. Notably, MTBE exposure was associated with increased amyloid precursor protein/β-amyloid-related pathology, suggesting involvement of molecular pathways linked to neurodegeneration. MTBE-exposed mice exhibited consistent motor impairments across multiple behavioral paradigms. Taken together, the results in this study identify MTBE as a developmental neurotoxicant that selectively compromises dopaminergic systems and establishes long-term neurological vulnerability. Therefore, it provides a potential link between environmental exposure and neurodegeneration-related processes.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Drugs Affecting Neurotransmitter Synthesis
Hepatic Encephalopathy
Teratogenicity

